Diffusion tensor imaging and magnetic resonance spectroscopy in a patient with adult onset tuberous sclerosis complex

J Clin Neurosci. 2018 Feb:48:108-110. doi: 10.1016/j.jocn.2017.10.072. Epub 2017 Nov 10.

Abstract

Tuberous sclerosis complex (TSC) 1 or TSC2 is mutated in most TSC patients. TSC2 mutations are more frequently associated with worse outcomes, earlier age at seizure onset, more severe intellectual disability, and higher tuber load than TSC1. The degree of white matter involvement is thought to be associated with the severity of neurological impairment. At present, genotype-phenotype correlations and relationship between tuber burden and neurological disability in TSC are debatable. We presented a 43-year-old patient with TSC2 mutation, whose symptom was only incomplete quadrantic visual field deficit in spite of multiple brain tubers. The visual field deficit was thought to be due to a small lesion in the upper medial part of the optic radiation revealed by diffusion tensor imaging. Her brain tubers showed normal findings in magnetic resonance spectroscopy. Our case suggested that neurological and neuropsychiatric manifestations of TSC are affected by the quality rather than number of the lesions. In addition, MRS may be useful to identify the correlation between brain tubers and neurological disability in TSC patients.

Keywords: Diffusion tensor imaging; Magnetic resonance spectroscopy; Quadrantanopia; TSC2; Tuberous sclerosis complex.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Brain / diagnostic imaging
  • Brain Chemistry / genetics
  • Diffusion Tensor Imaging / methods*
  • Disability Evaluation
  • Female
  • Humans
  • Magnetic Resonance Spectroscopy
  • Mutation
  • Tuberous Sclerosis / complications
  • Tuberous Sclerosis / diagnostic imaging*
  • Tuberous Sclerosis / genetics*
  • Tuberous Sclerosis Complex 2 Protein
  • Tumor Suppressor Proteins / genetics
  • Vision Disorders / diagnostic imaging
  • Vision Disorders / etiology
  • Visual Field Tests
  • Visual Fields

Substances

  • TSC2 protein, human
  • Tuberous Sclerosis Complex 2 Protein
  • Tumor Suppressor Proteins